TITLE

Myoepithelial expression of Fas and strong nuclear expression of FasL in epithelial cells: A marker for risk stratification of breast cancer

AUTHOR(S)
Ranade, K. J.; Nerurkar, A. V.; Phulpagar, M. D.; Shirsat, N. V.
PUB. DATE
January 2012
SOURCE
Indian Journal of Cancer;Jan-Mar2012, Vol. 49 Issue 1, p60
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
AIM: The clinical significance of Fas and FasL in hormone-sensitive carcinomas has been reported. Our objective was to evaluate the expression of apoptosis-regulating genes Fas and FasL in Indian breast cancer and fibroadenoma patients in relation to hormone receptor status. STUDY DESIGN: Retrospective. MATERIALS AND METHODS: Paraffin-embedded tissue samples from 63 untreated female patients with invasive ductal carcinoma (IDC) and 32 female patients with fibroadenoma were studied. Expression of Fas and FasL was evaluated using immunohistochemical staining method. STATISTICAL ANALYSIS: Fisher's exact test and nonparametric correlation test (Spearman rank correlation test) were performed. RESULT: Fas was detected in 97% of the fibroadenomas and there was a slight decrease in levels of expression with histological grades of IDC. The expression of FasL was detected in 75% fibroadenomas and its expression increased in IDC. There was no correlation between Fas, FasL expression and hormone receptor status. Strong expression of Fas in myoepithelial cells was noted in 12 out of 32 fibroadenoma cases. CONCLUSION: Expression of Fas and FasL alone is unlikely to be important as a predictive factor as they express in both normal and malignant breast epithelium. But strong expression of Fas in myoepithelial cells along with strong nuclear expression of FasL in epithelial cells of fibroadenoma could be useful as an early predictive factor for onset of malignancy.
ACCESSION #
78943702

 

Related Articles

  • MicroRNA-570-3p regulates HuR and cytokine expression in airway epithelial cells. Roff, Alanna N.; Craig, Timothy J.; August, Avery; Stellato, Cristiana; Ishmael, Faoud T. // American Journal of Clinical & Experimental Immunology;2014, Vol. 3 Issue 2, p68 

    Asthma is a chronic lung disease that affects people of all ages and is characterized by high morbidity. The mechanisms of asthma pathogenesis are unclear, and there is a need for development of diagnostic biomarkers and greater understanding of regulation of inflammatory responses in the lung....

  • Changes in Gene Expression and Cellular Architecture in an Ovarian Cancer Progression Model. Creekmore, Amy L.; Silkworth, William T.; Cimini, Daniela; Jensen, Roderick V.; Roberts, Paul C.; Schmelz, Eva M. // PLoS ONE;2011, Vol. 6 Issue 3, p1 

    Background: Ovarian cancer is the fifth leading cause of cancer deaths among women. Early stage disease often remains undetected due the lack of symptoms and reliable biomarkers. The identification of early genetic changes could provide insights into novel signaling pathways that may be...

  • Airway epithelial gene expression to detect lung cancer in smokers. Nanguzgambo, A. B. // Thorax;Sep2008, Vol. 63 Issue 9, p774 

    The article discusses a research which cites that gene expression in normal large airway epithelial cells can be used as a lung cancer biomarker and improve the diagnostic sensivity of bronchoscopy by supplementing the current cytopathological methods. Where facilities become availabel for...

  • PPARÏ’ deficiency results in reduced lung elastic recoil and abnormalities in airspace distribution. Simon, Dawn M.; Tsai, Larry W.; Ingenito, Edward P.; Starcher, Barry C.; Mariani, Thomas J. // Respiratory Research;2010, Vol. 11, p69 

    Background: Peroxisome proliferator-activated receptor (PPAR)-γ is a nuclear hormone receptor that regulates gene expression, cell proliferation and differentiation. We previously described airway epithelial cell PPARγ deficient mice that develop airspace enlargement with decreased tissue...

  • Biomarkers.  // Annals of Oncology;May2012 Supplement 2, Vol. 23 Issue suppl_2, pii17 

    No abstract available.

  • Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker.  // Breast Cancer Research;2012, Vol. 14 Issue 1, p3116 

    The article focuses on a study on male breast cancer ( MBC) and compares them with female breast cancer (FBC). The researchers classified the MBC tumors into two subgroups, luminal M1 and luminal M2, respectively. It is similar to female breast cancer (FBC) and is compared to post-menopausal...

  • The Role of MicroRNAs as Predictors of Response to Tamoxifen Treatment in Breast Cancer Patients. Egeland, Nina G.; Lunde, Siri; Jonsdottir, Kristin; Lende, Tone H.; Cronin-Fenton, Deirdre; Gilje, Bjørnar; Janssen, Emiel A. M.; Søiland, Håvard // International Journal of Molecular Sciences;2015, Vol. 16 Issue 10, p24243 

    Endocrine therapy is a key treatment strategy to control or eradicate hormone-responsive breast cancer. However, resistance to endocrine therapy leads to breast cancer relapse. The recent extension of adjuvant tamoxifen treatment up to 10 years actualizes the need for identifying biological...

  • A potential prognostic long non-coding RNA signature to predict metastasis-free survival of breast cancer patients. Sun, Jie; Chen, Xihai; Wang, Zhenzhen; Guo, Maoni; Shi, Hongbo; Wang, Xiaojun; Cheng, Liang; Zhou, Meng // Scientific Reports;11/13/2015, p16553 

    Long non-coding RNAs (lncRNAs) have been implicated in a variety of biological processes, and dysregulated lncRNAs have demonstrated potential roles as biomarkers and therapeutic targets for cancer prognosis and treatment. In this study, by repurposing microarray probes, we analyzed lncRNA...

  • Bcl-2 expression and triple negative profile in breast carcinoma. Kallel-Bayoudh, Imen; Hassen, Hanen; Khabir, Abdelmajid; Boujelbene, Noureddine; Daoud, Jamel; Frikha, Mounir; Sallemi-Boudawara, Tahia; Aifa, Sami; Rebaï, Ahmed // Medical Oncology;Dec2011, Vol. 28, p55 

    Many biomarkers for breast cancer prognosis have been proposed during the last two decades, among which HER2 and oestrogen receptors are of common use in routine clinical practice. However, in recent years, BCL2 has been recognized as an important prognostic parameter in human breast cancer,...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics